Skip to main content

Supportive Care in Cancer

Ausgabe Sonderheft 1/2011

Antiemetic Guidelines 2010 of the MASCC Antiemetic Study Group

Inhalt (10 Artikel)

Special Article

Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009

Petra Christine Feyer, Ernesto Maranzano, Alexander Molassiotis, Fausto Roila, Rebecca A. Clark-Snow, Karin Jordan

Special Article

Acute emesis: moderately emetogenic chemotherapy

Jørn Herrstedt, Bernardo Rapoport, David Warr, Fausto Roila, Emilio Bria, Cynthia Rittenberg, Paul J. Hesketh

Special Article

Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy

Mark G. Kris, Maurizio Tonato, Emilio Bria, Enzo Ballatori, Birgitte Espersen, Jørn Herrstedt, Cynthia Rittenberg, Lawrence H. Einhorn, Steven Grunberg, Mitsue Saito, Gary Morrow, Paul Hesketh

Special Article

Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential

Ian Olver, Rebecca A. Clark-Snow, Enzo Ballatori, Birgitte T. Espersen, Emilio Bria, Karin Jordan

Special Article

Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009

Karin Jordan, Fausto Roila, Alexander Molassiotis, Ernesto Maranzano, Rebecca A. Clark-Snow, Petra Feyer

Special Article

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—state of the art

Steven M. Grunberg, David Warr, Richard J. Gralla, Bernardo L. Rapoport, Paul J. Hesketh, Karin Jordan, Birgitte T. Espersen

Special Original Article

Antiemetic research: future directions

Ian Olver, Alexander Molassiotis, Matti Aapro, Jørn Herrstedt, Steven Grunberg, Garry Morrow

Special Article

Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only)

Fausto Roila, David Warr, Matti Aapro, Rebecca A. Clark-Snow, Larry Einhorn, Richard J. Gralla, Jorn Herrstedt, Mitsue Saito, Maurizio Tonato

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.